On the public citation graph
Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N -Propargylaminoindan Class
0 signed · 223 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1097-4547(19991101)58:3<456::aid-jnr12>3.0.co;2-sopenalex-snapshot
Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation
inferredcites →https://doi.org/10.1002/1098-2299(200007/08)50:3/4<216::aid-ddr4>3.0.co;2-zopenalex-snapshot
Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer's disease, with cholinesterase and monoamine oxidase inhibitory activities
inferredcites →https://doi.org/10.1006/prep.2000.1309openalex-snapshot
High-Level Expression of Human Liver Monoamine Oxidase B in Pichia pastoris
inferredcites →https://doi.org/10.1007/bf01250039openalex-snapshot
Biosynthesis of taurine by rat pinealsin vitro
inferredcites →https://doi.org/10.1021/jm020120copenalex-snapshot
Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease
inferredcites →https://doi.org/10.1021/jm0310885openalex-snapshot
Inactivation of Purified Human Recombinant Monoamine Oxidases A and B by Rasagiline and Its Analogues
inferredcites →https://doi.org/10.1023/a:1015131516649openalex-snapshot
Molecular Basis of Neuroprotective Activities of Rasagiline and the Anti-Alzheimer Drug TV3326 [lpar;N-Propargyl-(3R) Aminoindan-5-YL)-Ethyl Methyl Carbamate]
inferredcites →https://doi.org/10.1038/nsb732openalex-snapshot
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
inferredcites →https://doi.org/10.1073/pnas.1633804100openalex-snapshot
Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures
inferredcites →https://doi.org/10.1093/protein/8.2.127openalex-snapshot
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
inferredcites →https://doi.org/10.1107/s0021889891004387openalex-snapshot
EPITAX: a computer-assisted graphical representation of the bicrystallography of general interfaces
inferredcites →https://doi.org/10.1107/s0108767390010753openalex-snapshot
Near-coincidence orientations in hexagonal materials: from a unified twin approach to a quasiperiodic description
inferredcites →https://doi.org/10.1111/j.1749-6632.2001.tb03656.xopenalex-snapshot
The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4636655openalex-extracted
Probing the MAO Enzymes with a Novel Family of Quaternary Propargylamine Derivatives
inferred← citeshttps://doi.org/10.1002/9781119006039.ch13openalex-snapshot
USE OF KAVA AS A PHYTOTHERAPEUTIC AGENT AND KAVA‐RELATED HEPATOTOXICITY
inferred← citeshttps://doi.org/10.1002/9783527813421.ch10openalex-snapshot
Therapeutic Agents for Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1002/9783527813421.ch8openalex-snapshot
Enzymes Processing Neurotransmitters
inferred← citeshttps://doi.org/10.1002/ajoc.201500471openalex-snapshot
Tin(II) Chloride Catalyzed Multicomponent Synthesis of Propargylamines and Intramolecular [3+2] Cycloaddition
inferred← citeshttps://doi.org/10.1002/ajoc.201600623openalex-snapshot
CuI Supported on Protonated Trititanate Nanotubes: A Reusable Catalyst for the One‐Pot Synthesis of Propargylamines via A3‐Coupling
inferred← citeshttps://doi.org/10.1002/ange.201201955openalex-snapshot
Aktivitätsbasierte Sondenmoleküle zur Untersuchung der Aktivität Flavin‐abhängiger Oxidasen und zum Zielprotein‐Profiling von Monoaminooxidase‐Inhibitoren
inferred← citeshttps://doi.org/10.1002/anie.201201955openalex-snapshot
Activity‐Based Probes for Studying the Activity of Flavin‐Dependent Oxidases and for the Protein Target Profiling of Monoamine Oxidase Inhibitors
inferred← citeshttps://doi.org/10.1002/aoc.5395openalex-snapshot
Fibroin‐functionalized magnetic carbon nanotube as a green support for anchoring silver nanoparticles as a biocatalyst for A3 coupling reaction
inferred← citeshttps://doi.org/10.1002/ardp.201900177openalex-snapshot
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
inferred← citeshttps://doi.org/10.1002/cbic.200400053openalex-snapshot
Fluorinated Phenylcyclopropylamines as Inhibitors of Monoamine Oxidases
inferred← citeshttps://doi.org/10.1002/cbic.201600275openalex-snapshot
Fluorescent Mechanism‐Based Probe for Aerobic Flavin‐Dependent Enzyme Activity
inferred← citeshttps://doi.org/10.1002/cmdc.201100538openalex-snapshot
8‐Substituted 3‐Arylcoumarins as Potent and Selective MAO‐B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies
inferred← citeshttps://doi.org/10.1002/cmdc.201200484openalex-snapshot
Design, Synthesis, in vitro MAO‐B Inhibitory Evaluation, and Computational Studies of Some 6‐Nitrobenzothiazole‐Derived Semicarbazones
inferred← citeshttps://doi.org/10.1002/cmdc.201300533openalex-snapshot
Insight into the Functional and Structural Properties of 3‐Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition
inferred← citeshttps://doi.org/10.1002/cmdc.201402562openalex-snapshot
Design and Synthesis of a MAO‐B‐Selectively Activated Prodrug Based on MPTP: A Mitochondria‐Targeting Chemotherapeutic Agent for Treatment of Human Malignant Gliomas
inferred← citeshttps://doi.org/10.1002/cmdc.201500443openalex-snapshot
Discovery of 3‐Hydroxy‐3‐phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors
inferred← citeshttps://doi.org/10.1002/cmdc.202300705openalex-snapshot
Current Small Molecule–Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics
inferred← citeshttps://doi.org/10.1002/ejoc.201100873openalex-snapshot
Irreversible Inhibition of Monoamine Oxidase B by the Antiparkinsonian Medicines Rasagiline and Selegiline: A Computational Study
inferred← citeshttps://doi.org/10.1002/jccs.202000170openalex-snapshot
Imino isatin derivatives; synthesis, in silico molecular dynamic study over monoamine oxidase B, ADME prediction, and in vitro cytotoxicity evaluation
inferred← citeshttps://doi.org/10.1002/med.21561openalex-snapshot
Monoamine oxidase‐B inhibitors as potential neurotherapeutic agents: An overview and update
inferred← citeshttps://doi.org/10.1002/pauz.200600169openalex-snapshot
Enzyminhibitoren in der Parkinson‐Therapie. Unterstützung der Therapie mit L‐DOPA
inferred← citeshttps://doi.org/10.1002/prot.25894openalex-snapshot
Energetic contributions of amino acid residues and its cross‐talk to delineate ligand‐binding mechanism
inferred← citeshttps://doi.org/10.1002/prot.26783openalex-snapshot
Unraveling the Molecular Architecture of Mosquito D1 ‐Like Dopamine Receptors: Insights Into Ligand Binding and Structural Dynamics for Insecticide Development
inferred← citeshttps://doi.org/10.1002/psc.1226openalex-snapshot
Chemical tools in chromatin research
inferred← citeshttps://doi.org/10.1002/slct.201702141openalex-snapshot
Characterization of Thienylchalcones as hMAO‐B Inhibitors: Synthesis, Biochemistry and Molecular Dynamics Studies
inferred← citeshttps://doi.org/10.1002/slct.201702454openalex-snapshot
Progress in Synthesis of Propargylamine and Its Derivatives by Nanoparticle Catalysis via A3 coupling: A Decade Update
inferred← citeshttps://doi.org/10.1002/slct.202301727openalex-snapshot
Indole‐3‐carbinol (I3C): Inhibition Effect on Monoamine Oxidase A (MAO‐A), Monoamine Oxidase B (MAO‐B) and Cholinesterase Enzymes, Antioxidant Capacity and Molecular Docking Study
inferred← citeshttps://doi.org/10.1007/164_2020_384openalex-snapshot
Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches
inferred← citeshttps://doi.org/10.1007/978-1-0716-3662-6_24openalex-snapshot
Enzyme Inhibition Assays for Monoamine Oxidase
inferred← citeshttps://doi.org/10.1007/978-3-030-71519-9_211-1openalex-snapshot
Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30
inferred← citeshttps://doi.org/10.1007/978-3-031-15080-7_211openalex-snapshot
Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30
inferred← citeshttps://doi.org/10.1007/s00044-013-0704-3openalex-snapshot
Prospective atom-based 3D-QSAR model prediction, pharmacophore generation, and molecular docking study of carbamate derivatives as dual inhibitors of AChE and MAO-B for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1007/s00044-014-0941-0openalex-snapshot
Molecular modeling study on the structural basis of binding mechanism of C6-substituted phthalides with monoamine oxidases
inferred← citeshttps://doi.org/10.1007/s00253-007-1310-4openalex-snapshot
Discovery and characterization of a putrescine oxidase from Rhodococcus erythropolis NCIMB 11540
inferred← citeshttps://doi.org/10.1007/s00702-004-0143-xopenalex-snapshot
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson?s disease and other neurodegenerative diseases
inferred← citeshttps://doi.org/10.1007/s00702-007-0670-3openalex-snapshot
The aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine
inferred← citeshttps://doi.org/10.1007/s00702-007-0679-7openalex-snapshot
Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties
inferred← citeshttps://doi.org/10.1007/s00702-009-0225-xopenalex-snapshot
Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson’s disease drug, rasagiline compared with selegiline, in the rat midbrain
inferred← citeshttps://doi.org/10.1007/s00702-011-0635-4openalex-snapshot
Computational investigation on the structure–activity relationship of the biradical mechanism for monoamine oxidase
inferred← citeshttps://doi.org/10.1007/s00702-018-1861-9openalex-snapshot
Kinetics, mechanism, and inhibition of monoamine oxidase
inferred← citeshttps://doi.org/10.1007/s00702-023-02623-8openalex-snapshot
Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations
inferred← citeshttps://doi.org/10.1007/s10562-015-1679-0openalex-snapshot
Modified Montmorillonite Clay Stabilized Silver Nanoparticles: An Active Heterogeneous Catalytic System for the Synthesis of Propargylamines
inferred← citeshttps://doi.org/10.1007/s12562-016-1036-2openalex-snapshot
In vitro monoamine oxidase A and B inhibitory activity and molecular docking simulations of fucoxanthin
inferred← citeshttps://doi.org/10.1007/s12640-009-9128-8openalex-snapshot
Limited Potentiation of Blood Pressure in Response to Oral Tyramine by the Anti-Parkinson Brain Selective Multifunctional Monoamine Oxidase-AB Inhibitor, M30
inferred← citeshttps://doi.org/10.1016/b978-0-08-051337-9.50010-9openalex-snapshot
Enzyme Inhibition and Inactivation
inferred← citeshttps://doi.org/10.1016/b978-0-08-102432-4.00009-3openalex-snapshot
Clay mineral catalysts
inferred← citeshttps://doi.org/10.1016/b978-0-12-382030-3.00005-2openalex-snapshot
Enzyme Inhibition and Inactivation
inferred← citeshttps://doi.org/10.1016/b978-0-12-386467-3.00005-4openalex-snapshot
Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection
inferred← citeshttps://doi.org/10.1016/b978-0-12-386467-3.00007-8openalex-snapshot
Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-818349-6.00011-xopenalex-snapshot
Discovery of small molecules for the treatment of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/b978-0-444-53086-8.00015-1openalex-snapshot
Synthesis and Biochemical Evaluation of Fluorinated Monoamine Oxidase Inhibitors
inferred← citeshttps://doi.org/10.1016/j.abb.2025.110319openalex-snapshot
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenase
inferred← citeshttps://doi.org/10.1016/j.amjopharm.2006.12.001openalex-snapshot
Rasagiline (TVP-1012): A new selective monoamine oxidase inhibitor for Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.bbapap.2006.09.010openalex-snapshot
Do properties of bovine serum albumin at fluid/electrolyte interface follow the Hofmeister series?—An analysis using Langmuir and Langmuir–Blodgett films
inferred← citeshttps://doi.org/10.1016/j.bbapap.2013.11.003openalex-snapshot
Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: Role of Asn181 and Ile335 validated by spectroscopic and computational studies
inferred← citeshttps://doi.org/10.1016/j.bcp.2018.06.024openalex-snapshot
Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105070openalex-snapshot
Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105581openalex-snapshot
Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library
inferred← citeshttps://doi.org/10.1016/j.bmc.2005.04.081openalex-snapshot
Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity
inferred← citeshttps://doi.org/10.1016/j.bmc.2006.01.011openalex-snapshot
Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC)
inferred← citeshttps://doi.org/10.1016/j.bmc.2007.03.046openalex-snapshot
Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.02.014openalex-snapshot
Stereochemical studies on the novel monoamine oxidase B substrates (1R,6S)- and (1S,6R)-3-methyl-6-phenyl-3-aza-bicyclo[4.1.0]heptane
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.06.048openalex-snapshot
Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases A and B by 2-aryl-2-fluoro-cyclopropylamines
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.11.068openalex-snapshot
New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity
inferred← citeshttps://doi.org/10.1016/j.bmc.2009.07.033openalex-snapshot
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2009.12.065openalex-snapshot
Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2014.12.063openalex-snapshot
Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.06.045openalex-snapshot
Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2005.07.043openalex-snapshot
Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.12.108openalex-snapshot
Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs
inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.128746openalex-snapshot
The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.clinthera.2007.09.021openalex-snapshot
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease
inferred← citeshttps://doi.org/10.1016/j.comptc.2018.01.021openalex-snapshot
Recognition of trans and gauche phenylethylamine conformers in the active site of human monoamine oxidase B: A MD-simulation and DFT studies
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2025.100294openalex-snapshot
Molecules with alkyne fragment in medicinal chemistry: The path from neurotoxins to drugs
inferred← citeshttps://doi.org/10.1016/j.ejmech.2011.12.027openalex-snapshot
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B
inferred← citeshttps://doi.org/10.1016/j.ejmech.2012.10.035openalex-snapshot
Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.01.011openalex-snapshot
Crystal structures, binding interactions, and ADME evaluation of brain penetrant N -substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.03.009openalex-snapshot
MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.01.003openalex-snapshot
Privileged scaffolds as MAO inhibitors: Retrospect and prospects
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112282openalex-snapshot
N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112765openalex-snapshot
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
inferred← citeshttps://doi.org/10.1016/j.fob.2013.01.010openalex-snapshot
Irreversible inactivation of snake venom l ‐amino acid oxidase by covalent modification during catalysis of l ‐propargylglycine
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e06684openalex-snapshot
Binding mechanism of naringenin with monoamine oxidase – B enzyme: QM/MM and molecular dynamics perspective
inferred← citeshttps://doi.org/10.1016/j.jep.2019.112305openalex-snapshot
New role for crinamine as a potent, safe and selective inhibitor of human monoamine oxidase B: In vitro and in silico pharmacology and modeling
inferred← citeshttps://doi.org/10.1016/j.mad.2012.03.001openalex-snapshot
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
inferred← citeshttps://doi.org/10.1016/j.mcat.2018.01.013openalex-snapshot
Cu 2 O nanoparticles supported hydrothermal carbon microspheres as catalyst for propargylamine synthesis
inferred← citeshttps://doi.org/10.1016/j.mcn.2025.104037openalex-snapshot
Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention
inferred← citeshttps://doi.org/10.1016/j.molstruc.2016.11.019openalex-snapshot
Combined experimental and theoretical studies on the molecular structures, spectroscopy, and inhibitor activity of 3-(2-thienyl)acrylic acid through AIM, NBO,FT-IR, FT-Raman, UV and HOMO-LUMO analyses, and molecular docking
inferred← citeshttps://doi.org/10.1016/j.molstruc.2019.127351openalex-snapshot
Structural, docking and spectroscopic studies of a new piperazine derivative, 1-Phenylpiperazine-1,4-diium bis(hydrogen sulfate)
inferred← citeshttps://doi.org/10.1016/j.molstruc.2021.132280openalex-snapshot
Crystal structure, Hirshfeld surface analysis, and molecular dynamics simulations of two isostructural N-propargyl-4-(2-oxopyrrolidin-1-yl)-1,2,3,4-tetrahydroquinolines
inferred← citeshttps://doi.org/10.1016/j.molstruc.2026.146830openalex-snapshot
Crystal structure, hirshfeld surface analysis, DFT, NLO, and multi-target docking of a fluorinated 1,2,3-triazole diarylmethanol (4-FPh-TM)
inferred← citeshttps://doi.org/10.1016/j.pneurobio.2010.06.008openalex-snapshot
Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
inferred← citeshttps://doi.org/10.1016/j.pneurobio.2018.12.006openalex-snapshot
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.rechem.2023.101032openalex-snapshot
N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1016/j.tibs.2008.01.003openalex-snapshot
LSD1: oxidative chemistry for multifaceted functions in chromatin regulation
inferred← citeshttps://doi.org/10.1016/j.tibs.2017.02.005openalex-snapshot
Flavins as Covalent Catalysts: New Mechanisms Emerge
inferred← citeshttps://doi.org/10.1016/s0065-2423(06)43005-5openalex-snapshot
Methods for Predicting Human Drug Metabolism
inferred← citeshttps://doi.org/10.1021/acs.biochem.6c00163openalex-snapshot
Structural Principles of Covalent Flavin Modification in Oxidoreductases
inferred← citeshttps://doi.org/10.1021/acs.biochem.9b00213openalex-snapshot
Exposing the Interplay Between Enzyme Turnover, Protein Dynamics, and the Membrane Environment in Monoamine Oxidase B
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.2c00107openalex-snapshot
Antibody-Mediated Screening of Peptide Inhibitors for Monoamine Oxidase-B (MAO-B) from an Autodisplayed FV Library
inferred← citeshttps://doi.org/10.1021/acs.jafc.0c04504openalex-snapshot
Identification and Characterization of an Aspergillus niger Amine Oxidase that Detoxifies Intact Fumonisins
inferred← citeshttps://doi.org/10.1021/acs.jafc.2c06630openalex-snapshot
Screening of Monoamine Oxidase B Inhibitors from Fragaria nubicola by Ligand Fishing and Their Neuroprotective Effects
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00169openalex-snapshot
Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jcim.6b00608openalex-snapshot
Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure–Activity Relationships Predictive Models
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02644openalex-snapshot
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00599openalex-snapshot
Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b01588openalex-snapshot
Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00357openalex-snapshot
Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b01886openalex-snapshot
Stereoselective Activity of 1-Propargyl-4-styrylpiperidine-like Analogues That Can Discriminate between Monoamine Oxidase Isoforms A and B
inferred← citeshttps://doi.org/10.1021/acs.jpcb.4c08356openalex-snapshot
Benchmark CCSD(T) and Density Functional Theory Calculations of Biologically Relevant Catecholic Systems
inferred← citeshttps://doi.org/10.1021/acsami.5b10528openalex-snapshot
Light-Up Probes Based on Fluorogens with Aggregation-Induced Emission Characteristics for Monoamine Oxidase-A Activity Study in Solution and in Living Cells
inferred← citeshttps://doi.org/10.1021/acschemneuro.2c00261openalex-snapshot
Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
inferred← citeshttps://doi.org/10.1021/acschemneuro.8b00095openalex-snapshot
Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties
inferred← citeshttps://doi.org/10.1021/acschemneuro.9b00147openalex-snapshot
Computational Insight into the Mechanism of the Irreversible Inhibition of Monoamine Oxidase Enzymes by the Antiparkinsonian Propargylamine Inhibitors Rasagiline and Selegiline
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.6c00407openalex-snapshot
Decoupling Neuroprotection from MAO Inhibition via Indane-to-Azaindane Bioisosteric Replacement of Rasagiline
inferred← citeshttps://doi.org/10.1021/acsomega.5c00134openalex-snapshot
New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
inferred← citeshttps://doi.org/10.1021/acsomega.9b03960openalex-snapshot
Insight into Ginkgo biloba L. Extract on the Improved Spatial Learning and Memory by Chemogenomics Knowledgebase, Molecular Docking, Molecular Dynamics Simulation, and Bioassay Validations
inferred← citeshttps://doi.org/10.1021/acssuschemeng.5b00542openalex-snapshot
Sustainable and Versatile CuO/GNS Nanocatalyst for Highly Efficient Base Free Coupling Reactions
inferred← citeshttps://doi.org/10.1021/bi051847gopenalex-snapshot
Functional Role of the “Aromatic Cage” in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins,
inferred← citeshttps://doi.org/10.1021/bi800055wopenalex-snapshot
Structural Basis for the Inactivation of Thermus thermophilus Proline Dehydrogenase by N-Propargylglycine,
inferred← citeshttps://doi.org/10.1021/ja076090qopenalex-snapshot
Characterization of the Covalently Bound Anionic Flavin Radical in Monoamine Oxidase A by Electron Paramagnetic Resonance
inferred← citeshttps://doi.org/10.1021/jf403044mopenalex-snapshot
Construction of a Bifunctional Enzyme Fusion for the Combined Determination of Biogenic Amines in Foods
inferred← citeshttps://doi.org/10.1021/jm0310885openalex-snapshot
Inactivation of Purified Human Recombinant Monoamine Oxidases A and B by Rasagiline and Its Analogues
inferred← citeshttps://doi.org/10.1021/jm0506266openalex-snapshot
Binding of Rasagiline-Related Inhibitors to Human Monoamine Oxidases: A Kinetic and Crystallographic Analysis
inferred← citeshttps://doi.org/10.1021/jm0509849openalex-snapshot
A QSAR Model for in Silico Screening of MAO-A Inhibitors. Prediction, Synthesis, and Biological Assay of Novel Coumarins
inferred← citeshttps://doi.org/10.1021/jm070677yopenalex-snapshot
Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs
inferred← citeshttps://doi.org/10.1021/jm070728ropenalex-snapshot
Synthesis and Monoamine Oxidase Inhibitory Activity of New Pyridazine-, Pyrimidine- and 1,2,4-Triazine-Containing Tricyclic Derivatives
inferred← citeshttps://doi.org/10.1021/jm100120sopenalex-snapshot
Synthesis, Stereochemical Separation, and Biological Evaluation of Selective Inhibitors of Human MAO-B: 1-(4-Arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines
inferred← citeshttps://doi.org/10.1021/jm100337zopenalex-snapshot
Synthesis, in Vitro Activity, and Three-Dimensional Quantitative Structure−Activity Relationship of Novel Hydrazine Inhibitors of Human Vascular Adhesion Protein-1
inferred← citeshttps://doi.org/10.1021/jm200716yopenalex-snapshot
Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors
inferred← citeshttps://doi.org/10.1021/jm200853topenalex-snapshot
Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/jm201011xopenalex-snapshot
Novel Reversible Monoamine Oxidase A Inhibitors: Highly Potent and Selective 3-(1H-Pyrrol-3-yl)-2-oxazolidinones
inferred← citeshttps://doi.org/10.1021/jm500729aopenalex-snapshot
Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency
inferred← citeshttps://doi.org/10.1021/jm800656vopenalex-snapshot
Quantitative Structure−Activity Relationship and Complex Network Approach to Monoamine Oxidase A and B Inhibitors
inferred← citeshttps://doi.org/10.1021/jm9010127openalex-snapshot
Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B…
inferred← citeshttps://doi.org/10.1021/jp056020aopenalex-snapshot
Thermodynamics of Buried Water Clusters at a Protein−Ligand Binding Interface
inferred← citeshttps://doi.org/10.1038/nrn1883openalex-snapshot
The therapeutic potential of monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1039/c1gc15518kopenalex-snapshot
Nanocrystalline magnesium oxide stabilized gold nanoparticles: an advanced nanotechnology based recyclable heterogeneous catalyst platform for the one-pot synthesis of propargylamines
inferred← citeshttps://doi.org/10.1039/c1md00176kopenalex-snapshot
Identification of multifunctional small molecule-based reversible monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1039/c3cy00639eopenalex-snapshot
Efficient three-component coupling reactions catalyzed by Cu 0 -nanoparticles stabilized on modified montmorillonite
inferred← citeshttps://doi.org/10.1039/c4cy00666fopenalex-snapshot
Efficient one-pot synthesis of propargylamines catalysed by gold nanocrystals stabilized on montmorillonite
inferred← citeshttps://doi.org/10.1039/c4md00437jopenalex-snapshot
Synthesis and evaluation of 6-methylcoumarin derivatives as potent and selective monoamine oxidase B inhibitors
inferred← citeshttps://doi.org/10.1039/c5md00124bopenalex-snapshot
Chromanones: selective and reversible monoamine oxidase B inhibitors with nanomolar potency
inferred← citeshttps://doi.org/10.1039/c5ra20812bopenalex-snapshot
Facile synthesis of ZnAl 2 O 4 nanoparticles: efficient and reusable porous nano ZnAl 2 O 4 and copper supported on ZnAl 2 O 4 catalysts for one pot green synthesis of propargylamines and imidazo[1,2-a]pyridines by A 3 coupling reactions
inferred← citeshttps://doi.org/10.1039/c6md00586aopenalex-snapshot
Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1039/c9ra06693dopenalex-snapshot
ZnCl 2 loaded TiO 2 nanomaterial: an efficient green catalyst to one-pot solvent-free synthesis of propargylamines
inferred← citeshttps://doi.org/10.1063/5.0018526openalex-snapshot
Zwitterionic molten salt: An efficient organocatalyst for the one-pot synthesis of propargylamines
inferred← citeshttps://doi.org/10.1073/pnas.0504838102openalex-snapshot
Structure and activity of the axon guidance protein MICAL
inferred← citeshttps://doi.org/10.1073/pnas.0505975102openalex-snapshot
Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B
inferred← citeshttps://doi.org/10.1074/jbc.m500949200openalex-snapshot
Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors
inferred← citeshttps://doi.org/10.1080/01614940.2014.1003504openalex-snapshot
Recent Advances in Metal Nanoparticles Stabilization into Nanopores of Montmorillonite and Their Catalytic Applications for Fine Chemicals Synthesis
inferred← citeshttps://doi.org/10.1080/07391102.2017.1325405openalex-snapshot
Recognition dynamics of dopamine to human Monoamine oxidase B: role of Leu171/Gln206 and conserved water molecules in the active site cavity
inferred← citeshttps://doi.org/10.1080/07391102.2020.1802335openalex-snapshot
In silicodrug design and molecular docking studies targeting Akt1 (RAC-alpha serine/threonine-protein kinase) and Akt2 (RAC-beta serine/threonine-protein kinase) proteins and investigation of CYP (cytochrome P450) inhibitors against MAOB (monoamine oxidase B) for OSCC (oral squamous cell…
inferred← citeshttps://doi.org/10.1080/10425170500097925openalex-snapshot
Molecular cloning and characterization of monoamine oxidase A and B genes in pig
inferred← citeshttps://doi.org/10.1080/13543776.2018.1427735openalex-snapshot
MAO inhibitors and their wider applications: a patent review
inferred← citeshttps://doi.org/10.1080/13543776.2022.2083501openalex-snapshot
An updated patent review on monoamine oxidase (MAO) inhibitors
inferred← citeshttps://doi.org/10.1111/j.1471-4159.2005.03340.xopenalex-snapshot
Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition
inferred← citeshttps://doi.org/10.1111/j.1471-4159.2005.03341.xopenalex-snapshot
Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases.In vivoselective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion
inferred← citeshttps://doi.org/10.1111/j.1742-4658.2011.08386.xopenalex-snapshot
The ‘gating’ residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition
inferred← citeshttps://doi.org/10.1128/aem.00504-11openalex-snapshot
Small-Molecule Inhibition of Choline Catabolism in Pseudomonas aeruginosa and Other Aerobic Choline-Catabolizing Bacteria
inferred← citeshttps://doi.org/10.1155/2015/852194openalex-snapshot
Evaluation of the Inhibitory Effects of Bavachinin and Bavachin on Human Monoamine Oxidases A and B
inferred← citeshttps://doi.org/10.1159/000541362openalex-snapshot
Effects of Safinamide on Motor and Non-Motor Symptoms in Patients with Parkinson’s Disease and Motor Fluctuations
inferred← citeshttps://doi.org/10.1177/0091270005277935openalex-snapshot
Clinical Pharmacology of Rasagiline: A Novel, Second‐Generation Propargylamine for the Treatment of Parkinson Disease
inferred← citeshttps://doi.org/10.1186/s13321-024-00845-wopenalex-snapshot
Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B
inferred← citeshttps://doi.org/10.1186/s42269-023-01018-9openalex-snapshot
Design of new reversible and selective inhibitors of monoamine oxidase A and a comparison with drugs already approved
inferred← citeshttps://doi.org/10.1186/s43094-024-00589-2openalex-snapshot
Design, synthesis and in-vitro anti-depressant activity evaluation of some 2-styrylbenzimidazole derivatives
inferred← citeshttps://doi.org/10.1201/9781420073522.ch26openalex-snapshot
Iron and Monoamine Oxidase in Brain Function and Dysfunction
inferred← citeshttps://doi.org/10.1212/wnl.67.7_suppl_2.s5openalex-snapshot
Structure of the human mitochondrial monoamine oxidase B
inferred← citeshttps://doi.org/10.12955/pmp.v2.179openalex-snapshot
OPTIMIZING MOLECULAR DOCKING PROTOCOLS OF PYRROLE CONTAINING MAO-B INHIBITORS THROUGH CORRELATION COEFFICIENTS
inferred← citeshttps://doi.org/10.12955/pmp.v2.181openalex-snapshot
ANALYSIS OF DIFFERENT PREVENTIVE MEASURES TO IMPROVE HOME OFFICE ERGONOMICS – RESULTS FROM A STUDY ON THE FIRST WAVE OF THE COVID-19 PANDEMIC IN LATVIA
inferred← citeshttps://doi.org/10.13140/rg.2.2.30232.44800openalex-snapshot
Identification of novel scaffolds for Monoamine oxidase B inhibitors.
inferred← citeshttps://doi.org/10.1371/journal.pone.0099894openalex-snapshot
A New F131V Mutation in Chlamydomonas Phytoene Desaturase Locates a Cluster of Norflurazon Resistance Mutations near the FAD-Binding Site in 3D Protein Models
inferred← citeshttps://doi.org/10.1371/journal.pone.0200637openalex-snapshot
3D similarities between the binding sites of monoaminergic target proteins
inferred← citeshttps://doi.org/10.1517/13543776.15.12.1763openalex-snapshot
Recent development of monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1586/ern.09.68openalex-snapshot
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease
inferred← citeshttps://doi.org/10.2146/ajhp050395openalex-snapshot
Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson’s disease
inferred← citeshttps://doi.org/10.2147/jep.s34343openalex-snapshot
Investigational agents in the treatment of Parkinson's disease: focus on safinamide
inferred← citeshttps://doi.org/10.2147/ndt.s25142openalex-snapshot
Adjunctive therapy in Parkinson's disease: the role of rasagiline
inferred← citeshttps://doi.org/10.2174/0118715273367688250528122144openalex-snapshot
Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways
inferred← citeshttps://doi.org/10.2174/0118756921356303250414025054openalex-snapshot
Zinda Tilismath, A Unani Medicine in Parkinson’s Disease: Preclinical Investigation and Docking Studies with MAO-B and PINK 1 Gene
inferred← citeshttps://doi.org/10.2174/138955712802762383openalex-snapshot
Monoamino Oxidase A: An Interesting Pharmacological Target for the Development of Multi-Target QSAR
inferred← citeshttps://doi.org/10.2174/1389557520666200302114620openalex-snapshot
Single Heterocyclic Compounds as Monoamine Oxidase Inhibitors: From Past to Present
inferred← citeshttps://doi.org/10.2174/156802612805220002openalex-snapshot
Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
inferred← citeshttps://doi.org/10.2174/1568026615666150427113103openalex-snapshot
Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors
inferred← citeshttps://doi.org/10.2174/1570159x21666230221123059openalex-snapshot
Computational Studies Applied to Linalool and Citronellal Derivatives Against Alzheimer's and Parkinson's Disorders: A Review with Experimental Approach
inferred← citeshttps://doi.org/10.2174/1871527321666211231100255openalex-snapshot
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update
inferred← citeshttps://doi.org/10.33084/jmd.v1i1.2357openalex-snapshot
Suitable Docking Protocol for the Design of Novel Coumarin Derivatives with Selective MAO-B Effects
inferred← citeshttps://doi.org/10.3389/fchem.2018.00169openalex-snapshot
Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism
inferred← citeshttps://doi.org/10.3389/fnins.2022.807435openalex-snapshot
Imaging of Reactive Astrogliosis by Positron Emission Tomography
inferred← citeshttps://doi.org/10.3389/fnmol.2019.00143openalex-snapshot
Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis
inferred← citeshttps://doi.org/10.3389/fphar.2019.01590openalex-snapshot
Amphetamine Derivatives as Monoamine Oxidase Inhibitors
inferred← citeshttps://doi.org/10.3390/antiox11050884openalex-snapshot
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease
inferred← citeshttps://doi.org/10.3390/cells12050763openalex-snapshot
The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
inferred← citeshttps://doi.org/10.3390/chemistry3030069openalex-snapshot
Questions in the Chemical Enzymology of MAO
inferred← citeshttps://doi.org/10.3390/ecsoc-12-01239openalex-snapshot
Design, Synthesis and Pharmacological Evaluation of New Coumarin Derivatives as Monoamine Oxidase A and B Inhibitors
inferred← citeshttps://doi.org/10.3390/ijms17040525openalex-snapshot
Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?
inferred← citeshttps://doi.org/10.3390/ijms21207648openalex-snapshot
Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein–Inhibitor Complexes in Relevance to Developing Parkinson’s Therapeutics
inferred← citeshttps://doi.org/10.3390/ijms26052363openalex-snapshot
Revealing Lingonberry’s Neuroprotective Potential in Alzheimer’s Disease Through Network Pharmacology and Molecular Docking
inferred← citeshttps://doi.org/10.3390/md17040221openalex-snapshot
Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease
showing the first 200 of 210 · page through all 210
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.